Article

PTEN deficiency exposes a requirement for an ARF GTPase module in integrin-dependent…

medRxiv · 2022 · Konstantina Nikolatou, author Emma Sandilands, author Alvaro Román-Fernández, author Erin M. Cumming, author Eva Freckmann, author Sergio Lilla, author Lori Buetow, author Lynn McGarry, author Matthew Neilson, author Robin Shaw, author David Strachan, author Crispin Miller, author Danny T. Huang, author Iain A. McNeish, author James C. Norman, author Sara Zanivan, author David M. Bryant, author

Key facts

Title PTEN deficiency exposes a requirement for an ARF GTPase module in integrin-dependent invasion in ovarian cancer.
First author Konstantina Nikolatou, author Emma Sandilands, author Alvaro Román-Fernández, author Erin M. Cumming, author Eva Freckmann, author Sergio Lilla, author Lori Buetow, author Lynn McGarry, author Matthew Neilson, author Robin Shaw, author David Strachan, author Crispin Miller, author Danny T. Huang, author Iain A. McNeish, author James C. Norman, author Sara Zanivan, author David M. Bryant, author
Journal medRxiv
Published Dec 1, 2022
DOI 10.1101/2022.11.29.518198
Devices mentioned BK110039, DEN000008, K022086, K103302, K800781, K802418
Product codes mentioned JCI, JCJ, JJH, KIP, KIT, MVU, NDS, NJT, OOI, PFT, KIS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature